Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine and Dopaminergic Epigenetic Control
NCT00370500Phase 4Completed
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Start
- Apr 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine in schizophrenia, sponsored by FAU Erlangen-Nürnberg Medical Faculty. Started Apr 2007; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00370500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00370500.